Middle-East & Africa Nuclear Medicine Radiopharmaceuticals Market By Diagnostics (SPECT, PET), By Therapeutics (Beta Emitters, Alpha Emitters, Brachytherapy), By Application (cardiology, Lymphoma, Thyroid, Neurology Oncology) And By Region - Global Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2018–2023)

Middle-East & Africa Nuclear Medicine Radiopharmaceuticals Market By Diagnostics (SPECT, PET), By Therapeutics (Beta Emitters, Alpha Emitters, Brachytherapy), By Application (cardiology, Lymphoma, Thyroid, Neurology Oncology) And By Region - Global Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2018–2023)

ID: 134 | Pages: 145 | October 2018 | Region: Middle East and Africa


Nuclear medicine falls under the field of Molecular Imaging, which involves usage of a minute amount of radioactive material (radiopharmaceuticals) to diagnose and treat disease.

Middle-East & Africa Nuclear Medicine Radiopharmaceuticals Market estimated at $0.71 billion in 2018 and is expected to reach $1.95 billion by 2023, growing at a CAGR of 22.11%.

Increasing incidence of cancer and cardiac ailments, immense technological advancements, increasing demand for SPECT and PET applications along with the growing public awareness for healthcare are fuelling the growth of Radiopharmaceuticals market. Further, Integration of X ray tomography (CT) into SPECT have recently emerged as an excellent diagnostic tool in medical imaging and is considered to be a driving factor for the growth of the market. Strict regulatory framework pose a major hurdle to the translational research and clinical investigations and reimbursement issues are blocking the growth of the Radiopharmaceuticals market. In addition, short half-life of radiopharmaceuticals and competition from orthodox diagnostic procedures are also restraining the Middle-East & Africa nuclear medicine Radioisotopes market.

The market of radiopharmaceuticals is segmented into Diagnostic radioisotopes and Therapeutic radioisotopes. Diagnostic radioisotope market is further sub segmented into SPECT (Technetium-99m, Thallium-201 Gallium-67, Iodine) and PET (Fluorine-18, Rubidium-82) radioisotopes. Therapeutic radioisotopes cover Beta emitters (Iodine-131, Yttrium-90, Samarium-153, Rhenium-186, Lutetium-177), Alpha Emitters (Radium-223) and Brachytherapy (Cesium-131, Iodine-125, Palladium-103, Iridium-192). By application market is segmented into (cardiology, lymphoma, thyroid, neurology oncology, and others). Furthermore, on the basis of geography, the Middle-East & Africa Market is segmented under various regions namely, UAE, Saudi Arabia, Israel and South Africa.

Radiopharmaceuticals market is dominated by diagnostic radioisotopes and is expected to have a market share of 90 % of the radiopharmaceuticals market while therapeutic radioisotopes contribute 10% of the market. Based on type of radioisotopes the market is segmented into Technetium-99m (TC-99m), Thallium-201 (TL-201), Fluorine-18,Iodine (I-123), Rubidium-82 (RB-82) and others. The F-18 market is mostly contributed by F-18 FDG tracers though this market is enriched with future tracers such as F-18 Florbetapir and F-18 Choline. The promising clinical outcome of these tracers has gained the business interest of major research institutes and PET isotope players. Ga-68 and Rb-82 are two other potential isotopes in the PET diagnostic market, ensuring high growth of the diagnostics segment. Diagnosis of coronary artery disease, bone metastasis, and Alzheimer’s disease are the most promising indications for the future PET radioisotopes market.

Some of the key players influencing the Middle-East & Africa nuclear medicine market are GE Healthcare, Hologic Inc., Medix Inc., Segami Corporation,Positron Corporation,Bracco Imaging S.p.A, Naviscan Inc., Bayer Healthcare, Lantheus Medical Imaging, Inc. and IBA Molecular Imaging.

1.Introduction                                                  

                1.1 Market Definition                                    

                1.2 Study Deliverables                                  

                1.3 Base Currency, Base Year and Forecast Periods                                           

                1.4 General Study Assumptions                                

2. Research Methodology                                                           

                2.1 Introduction                                              

                2.2 Analysis Design                                         

                2.3 Research Phases                                      

                                2.3.1 Secondary Research                            

                                2.3.2 Primary Research                 

                                2.3.3 Econometric Modelling                     

                                2.3.4 Expert Validation                  

                2.4 Study Timeline                                          

3. Overview                                                      

                3.1 Executive Summary                                

                3.2 Key Inferences                                         

                3.3 New Developments                                

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                      

                4.1 Market Drivers                                          

                4.2 Market Restraints                                    

                4.3 Key Challenges                                         

                4.4 Current Opportunities in the Market                               

5. Market Segmentation                                                              

                5.1 By Type                                        

                                5.1.1 Diagnostic Radioisotopes                 

                                                5.1.1.1 SPECT    

                                                                5.1.1.1.1 Technetium-99m

                                                                5.1.1.1.2 Thallium-201

                                                                5.1.1.1.3 Gallium-67

                                                                5.1.1.1.4 Iodine-23

                                                                5.1.1.1.5 Others

                                                5.1.1.2 PET         

                                                                5.1.1.2.1 Fluorine-18

                                                                5.1.1.2.2 Rubidium-82

                                                                5.1.1.2.3 Others

                                5.1.2 Therapeutic Radioisotopes                              

                                                5.1.2.1 Beta Emitters     

                                                                5.1.2.1.1 Iodine-131

                                                                5.1.2.1.2 Yttrium-90

                                                                5.1.2.1.3 Samarium-153

                                                                5.1.2.1.4 Rhenium-186

                                                                5.1.2.1.5 Lutetium-177

                                                5.1.2.2 Alpha Emitters   

                                                                5.1.2.2.1 Radium-223

                                                5.1.2.3 Brachytherapy   

                                                                5.1.2.3.1 Cesium-131

                                                                5.1.2.3.2 Iodine-125

                                                                5.1.2.3.3 Palladium-103

                                                                5.1.2.3.4 Iridium-192

                5.2 By Application                                           

                                5.2.1 Cardiology                               

                                5.2.2 Lymphoma                             

                                5.2.3 Thyroid                     

                                5.2.4 Neurology               

                                5.2.5 Oncology                 

                                5.2.6 Others                      

6. Geographical Analysis                                                              

                                6.1 UAE               

                                6.2 Saudi Arabia                               

                                6.3 Israel                             

                                6.4 South Africa               

7.Strategic Analysis                                                        

                7.1 PESTLE analysis                                         

                                7.1.1 Political                     

                                7.1.2 Economic                 

                                7.1.3 Social                         

                                7.1.4 Technological                         

                                7.1.5 Legal                          

                                7.1.6 Environmental                      

                7.2 Porter’s Five analysis                                              

                                7.2.1 Bargaining Power of Suppliers                        

                                7.2.2 Bargaining Power of Consumers                    

                                7.2.3 Threat of New Entrants                     

                                7.2.4 Threat of Substitute Products and Services               

                                7.2.5 Competitive Rivalry within the Industry                      

8.Market Leaders' Analysis                                                          

                8.1 GE Healthcare                                           

                                8.1.1 Overview                

                                8.1.2 Product Analysis                   

                                8.1.3 Strategic Evaluation and Operations                            

                                8.1.4 Financial analysis                  

                                8.1.5 Legal issues                            

                                8.1.6 Recent Developments                       

                                8.1.7 SWOT analysis                       

                                8.1.8 Analyst View                          

                8.2 Hologic Inc.                                

                8.3 Segami Corporation                                

                8.4 Positron Corporation                                              

                8.5 Bracco Imaging S.P.A                                              

                8.6 Naviscan Inc.                                              

                8.7 Bayer Healthcare                                     

                8.8 Lantheus Medical Imaging Inc.                                           

                8.9 IBA Molecular Imaging                                           

                8.10 Medix Inc.                                

9.Competitive Landscape                                                            

                9.1 Market share analysis                                            

                9.2 Merger and Acquisition Analysis                                        

                9.3 Agreements, collaborations and Joint Ventures                                          

                9.4 New Product Launches                                          

10.Expert Opinions                                                         

                10.1 Market Outlook                                     

                10.2 Investment Opportunities                                 

Appendix                                                           

                a) List of Tables                                

                b) List of Figures                                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Middle East & Africa Nuclear Medicine Radiopharmaceuticals Market By Region, From 2018-2023 (USD Million)
  2. Middle East & Africa Nuclear Medicine Radiopharmaceuticals Market By Type, From 2018-2023 (USD Million)
  3. Middle East & Africa Diagnostic Radioisotopes Market By Region, From 2018-2023 (USD Million)
  4. Middle East & Africa Therapeutic Radioisotopes Market By Region, From 2018-2023 (USD Million)
  5. Middle East & Africa Nuclear Medicine Radiopharmaceuticals Market By Application, From 2018-2023 (USD Million)
  6. Middle East & Africa Cardiology Market By Region, From 2018-2023 (USD Million)
  7. Middle East & Africa Lymphoma Market By Region, From 2018-2023 (USD Million)
  8. Middle East & Africa Thyroid Market By Region, From 2018-2023 (USD Million)
  9. Middle East & Africa Neurology Market By Region, From 2018-2023 (USD Million)
  10. Middle East & Africa Oncology Market By Region, From 2018-2023 (USD Million)
  11. Middle East & Africa Other Applications Market By Region, From 2018-2023 (USD Million)
  12. Middle East & Africa Diagnostic Radioisotopes Market By Type, From 2018-2023 ( USD Million )
  13. Middle East & Africa SPECT Diagnostic Radioisotopes Market By Region, From 2018-2023 ( USD Million )
  14. Middle East & Africa PET Diagnostic Radioisotopes Market By Region, From 2018-2023 ( USD Million )
  15. Middle East & Africa Other Diagnostic Radioisotopes Market By Region, From 2018-2023 ( USD Million )
  16. Middle East & Africa SPECT Diagnostic Radioisotopes Market By Type, From 2018-2023 ( USD Million )
  17. Middle East & Africa Technetium-99m Market By Region, From 2018-2023 ( USD Million )
  18. Middle East & Africa Thallium-201 Market By Region, From 2018-2023 ( USD Million )
  19. Middle East & Africa Gallium-67 Market By Region, From 2018-2023 ( USD Million )
  20. Middle East & Africa Iodine-23 Market By Region, From 2018-2023 ( USD Million )
  21. Middle East & Africa Other SPECT Diagnostic Radioisotopes Market By Region, From 2018-2023 ( USD Million )
  22. Middle East & Africa PET Diagnostic Radioisotopes Market By Type, From 2018-2023 ( USD Million )
  23. Middle East & Africa Fluorine-18 Market By Region, From 2018-2023 ( USD Million )
  24. Middle East & Africa Rubidium-82 Market By Region, From 2018-2023 ( USD Million )
  25. Middle East & Africa Other PET Diagnostic Radioisotopes Market By Region, From 2018-2023 ( USD Million )
  26. Middle East & Africa Therapeutic Radioisotopes Market By Type, From 2018-2023 ( USD Million )
  27. Middle East & Africa Beta Emitters Market By Region, From 2018-2023 ( USD Million )
  28. Middle East & Africa Alpha Emitters Market By Region, From 2018-2023 ( USD Million )
  29. Middle East & Africa Brachytherapy Market By Region, From 2018-2023 ( USD Million )
  30. Middle East & Africa Beta Emitters Market By Type, From 2018-2023 ( USD Million )
  31. Middle East & Africa Iodine-131 Market By Region, From 2018-2023 ( USD Million )
  32. Middle East & Africa Yttrium-90 Market By Region, From 2018-2023 ( USD Million )
  33. Middle East & Africa Samarium-153 Market By Region, From 2018-2023 ( USD Million )
  34. Middle East & Africa Rhenium-186 Market By Region, From 2018-2023 ( USD Million )
  35. Middle East & Africa Lutetium-177 Market By Region, From 2018-2023 ( USD Million )
  36. Middle East & Africa Alpha Emitters Market By Type, From 2018-2023 ( USD Million )
  37. Middle East & Africa Radium-223 Market By Region, From 2018-2023 ( USD Million )
  38. Middle East & Africa Other Alpha Emitters Market By Region, From 2018-2023 ( USD Million )
  39. Middle East & Africa Brachytherapy Market By Type, From 2018-2023 ( USD Million )
  40. Middle East & Africa Cesium-131 Market By Region, From 2018-2023 ( USD Million )
  41. Middle East & Africa Iodine-125 Market By Region, From 2018-2023 ( USD Million )
  42. Middle East & Africa Palladium-103 Market By Region, From 2018-2023 ( USD Million )
  43. Middle East & Africa Iridium-192 Market By Region, From 2018-2023 ( USD Million )
  44. UAE Nuclear Medicine Radiopharmaceuticals Market By Type, From 2018-2023 (USD Million)
  45. UAE Nuclear Medicine Radiopharmaceuticals Market By Application, From 2018-2023 (USD Million)
  46. Saudi Arabia Nuclear Medicine Radiopharmaceuticals Market By Type, From 2018-2023 (USD Million)
  47. Saudi Arabia Nuclear Medicine Radiopharmaceuticals Market By Application, From 2018-2023 (USD Million)
  48. Israel Nuclear Medicine Radiopharmaceuticals Market By Type, From 2018-2023 (USD Million)
  49. Israel Nuclear Medicine Radiopharmaceuticals Market By Application, From 2018-2023 (USD Million)
  50. South Africa Nuclear Medicine Radiopharmaceuticals Market By Type, From 2018-2023 (USD Million)
  51. South Africa Nuclear Medicine Radiopharmaceuticals Market By Application, From 2018-2023 (USD Million)
  52. UAE Diagnostic Radioisotopes Market By Type, From 2018-2023 ( USD Million )
  53. Saudi Arabia Diagnostic Radioisotopes Market By Type, From 2018-2023 ( USD Million )
  54. Israel Diagnostic Radioisotopes Market By Type, From 2018-2023 ( USD Million )
  55. South Africa Diagnostic Radioisotopes Market By Type, From 2018-2023 ( USD Million )
  56. UAE SPECT Diagnostic Radioisotopes Market By Type, From 2018-2023 ( USD Million )
  57. Saudi Arabia SPECT Diagnostic Radioisotopes Market By Type, From 2018-2023 ( USD Million )
  58. Israel SPECT Diagnostic Radioisotopes Market By Type, From 2018-2023 ( USD Million )
  59. South Africa SPECT Diagnostic Radioisotopes Market By Type, From 2018-2023 ( USD Million )
  60. UAE PET Diagnostic Radioisotopes Market By Type, From 2018-2023 ( USD Million )
  61. Saudi Arabia PET Diagnostic Radioisotopes Market By Type, From 2018-2023 ( USD Million )
  62. Israel PET Diagnostic Radioisotopes Market By Type, From 2018-2023 ( USD Million )
  63. South Africa PET Diagnostic Radioisotopes Market By Type, From 2018-2023 ( USD Million )
  64. UAE Therapeutic Radioisotopes Market By Type, From 2018-2023 ( USD Million )
  65. Saudi Arabia Therapeutic Radioisotopes Market By Type, From 2018-2023 ( USD Million )
  66. Israel Therapeutic Radioisotopes Market By Type, From 2018-2023 ( USD Million )
  67. South Africa Therapeutic Radioisotopes Market By Type, From 2018-2023 ( USD Million )
  68. UAE Beta Emitters Market By Type, From 2018-2023 ( USD Million )
  69. Saudi Arabia Beta Emitters Market By Type, From 2018-2023 ( USD Million )
  70. Israel Beta Emitters Market By Type, From 2018-2023 ( USD Million )
  71. South Africa Beta Emitters Market By Type, From 2018-2023 ( USD Million )
  72. UAE Alpha Emitters Market By Type, From 2018-2023 ( USD Million )
  73. Saudi Arabia Alpha Emitters Market By Type, From 2018-2023 ( USD Million )
  74. Israel Alpha Emitters Market By Type, From 2018-2023 ( USD Million )
  75. South Africa Alpha Emitters Market By Type, From 2018-2023 ( USD Million )
  76. UAE Brachytherapy Market By Type, From 2018-2023 ( USD Million )
  77. Saudi Arabia Brachytherapy Market By Type, From 2018-2023 ( USD Million )
  78. Israel Brachytherapy Market By Type, From 2018-2023 ( USD Million )
  79. South Africa Brachytherapy Market By Type, From 2018-2023 ( USD Million )
Middle East And Africa Angina Pectoris Drugs Market By Therapeutic Class ( Beta Blockers, Calcium Antagonists, Anticoagulants, Anti-platelets And Others) And By Region - Global Industry Analysis, Size, Share, Growth...
Asia Pacific Angina Pectoris Drugs Market By Therapeutic Class (beta Blockers, Calcium Antagonists, Anticoagulants, Anti-platelets And Others) And By Region - Global Industry Analysis, Size, Share, Growth, Trends, A...
Europe Angina Pectoris Drugs Market By Therapeutic Class ( Beta Blockers, Calcium Antagonists, Anticoagulants, Anti-platelets And Others) And By Region - Global Industry Analysis, Size, Share, Growth, Trends, And Fo...
North America Angina Pectoris Drugs Market By Therapeutic Class (beta Blockers, Calcium Antagonists, Anticoagulants, Anti-platelets And Others) And By Region - Global Industry Analysis, Size, Share, Growth, Trends, ...
Angina Pectoris Drugs Market By Therapeutic Class (beta Blockers, Calcium Antagonists, Anticoagulants, Anti-platelets And Others) And By Region - Global Industry Analysis, Size, Share, Growth, Trends, And Forecasts ...
Middle East And Africa Schizophrenia Drugs Agents Market By Therapeutic Class ( Second Generation Anti-psychotics, Third Generation Anti-psychotics And Others) , By Treatment ( Oral And Injectable Anti-psychotics) A...
Latin America Schizophrenia Drugs Agents Market By Therapeutic Class ( Second Generation Anti-psychotics, Third Generation Anti-psychotics And Others) , By Treatment ( Oral And Injectable Anti-psychotics) And By Reg...
Asia Pacific Schizophrenia Drugs Agents Market By Therapeutic Class ( Second Generation Anti-psychotics, Third Generation Anti-psychotics And Others) , By Treatment ( Oral And Injectable Anti-psychotics) And By Regi...
Europe Schizophrenia Drugs Agents Market By Therapeutic Class ( Second Generation Anti-psychotics, Third Generation Anti-psychotics And Others) , By Treatment ( Oral And Injectable Anti-psychotics) And By Region - I...
North America Schizophrenia Drugs Agents Market By Therapeutic Class ( Second Generation Anti-psychotics, Third Generation Anti-psychotics And Others) , By Treatment ( Oral And Injectable Anti-psychotics) And By Reg...
Schizophrenia Drugs Agents Market By Therapeutic Class ( Second Generation Anti-psychotics, Third Generation Anti-psychotics And Others) , By Treatment ( Oral And Injectable Anti-psychotics) And By Region - Industry...
Pharmaceutical Gelatin Market By Function (stabilizers, Thickeners, Gelling Agents And Others) , By Source( Pig Skin, Bovine Hides, Bones And Others), By Application ( Hard Capsules, Soft Capsules, Microencapsulatio...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2018 Market Data Forecast
All Rights Reserved.